Abstract
Recent advances in stem-cell technology are now allowing the mechanisms of human disease to be studied in human cells. A new era for regenerative medicine is arising from such disease models, extending beyond early cell-based therapies and towards evaluating genetic variation in humans and identifying the molecular pathways that lead to disease, as well as targets for therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cowan, C. A. et al. Derivation of embryonic stem-cell lines from human blastocysts. N. Engl. J. Med. 350, 1353–1356 (2004).
Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).
Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).
Osafune, K. et al. Marked differences in differentiation propensity among human embryonic stem cell lines. Nature Biotechnol. 26, 313–315 (2008).
Laugwitz, K. L., Moretti, A., Caron, L., Nakano, A. & Chien, K. R. Islet1 cardiovascular progenitors: a single source for heart lineages? Development 135, 193–205 (2008).
Laugwitz, K. L. et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433, 647–653 (2005).
Moretti, A. et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127, 1151–1165 (2006).
Qyang, Y. et al. The in vivo renewal and differentiation of Isl1+ cardiovascular progenitors is controlled by a Wnt/β-catenin pathway. Cell Stem Cell 1, 165–179 (2007).
Wu, S. M. et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 127, 1137–1150 (2006).
Kattman, S. J., Huber, T. L. & Keller, G. M. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell 11, 723–732 (2006).
Feinberg, A. W. et al. Muscular thin films for building actuators and powering devices. Science 317, 1366–1370 (2007).
Ott, H. C. et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nature Med. 14, 213–221 (2008).
Slepian, M. J. & Copeland, J. G. The total artificial heart in refractory cardiogenic shock: saving the patient versus saving the heart. Nature Clin. Pract. Cardiovasc. Med. 5, 64–65 (2008).
Mather, P. J. & Konstam, M. A. Newer mechanical devices in the management of acute heart failure. Heart Fail. Rev. 12, 167–172 (2007).
Kaye, D. M., Hoshijima, M. & Chien, K. R. Reversing advanced heart failure by targeting Ca2+ cycling. Annu. Rev. Med. 59, 13–28 (2008).
Martin-Puig, S., Wang, Z. & Chien, K. R. Lives of a heart cell: tracing the origins of cardiac progenitors. Cell Stem Cell 2, 320–331 (2008).
Acknowledgements
The author is supported by grants from Massachusetts General Hospital, the Harvard Stem Cell Institute, Fondation Leducq and the National Institutes of Health. This article is dedicated to N. E. Shumway.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
K.R.C. is a founder of Celladon, a biotechnology company that develops treatments for cardiovascular disease.
Additional information
Correspondence should be addressed to the author (kchien@partners.org).
Rights and permissions
About this article
Cite this article
Chien, K. Regenerative medicine and human models of human disease. Nature 453, 302–305 (2008). https://doi.org/10.1038/nature07037
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature07037
This article is cited by
-
Optogenetically mediated large volume suppression and synchronized excitation of human ventricular cardiomyocytes
Pflügers Archiv - European Journal of Physiology (2023)
-
Phytoconstituents for Boosting the Stem Cells Used in Regenerative Medicine
Current Pharmacology Reports (2023)
-
Cardiovascular surgery for realization of regenerative medicine
General Thoracic and Cardiovascular Surgery (2012)
-
Capture of endothelial progenitor cells by a bispecific protein/monoclonal antibody molecule induces reendothelialization of vascular lesions
Journal of Molecular Medicine (2010)
-
Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cells
BMC Genomics (2009)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.